Skip to main content
. 2018 Oct 16;9(81):35251–35265. doi: 10.18632/oncotarget.25834

Figure 2.

Figure 2

Kaplan-Meyer progression-free survival curves according to response to therapies (A: SRT; B: chemotherapy), and extent of disease (C: type of involved organ; D: total number of metastases). See Table 6 for P at log-rank test.